Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring. Many patients with fungal infections require prolonged therapy due to resistance or intolerance to oral antifungal agents. Despite the widespread use of OPAT by infection specialists, antifungal agents appear infrequently used in this setting. We suggest that with appropriate patient selection, patients with fungal infections could successfully be treated on OPAT. This article is protected by copyright. All rights reserved.</p
Introduction: Outpatient parenteral antimicrobial therapy (OPAT) has gained popularity since its fir...
Objective: Evaluate evidence of the efficacy, safety, acceptability and cost-effectiveness of outpat...
Traditionally, outpatient parenteral antimicrobial therapy (OPAT) is used to treat infections with p...
Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients w...
Background Antifungal administration via outpatient parenteral antimicrobial therapy (OPAT) is in...
WHAT IS KNOWN AND OBJECTIVE: Outpatient parenteral therapy (OPAT) has become a safe and effective mo...
Aim Outpatient parenteral antimicrobial therapy (OPAT) is an option in patients who require parente...
Outpatient parenteral antimicrobial therapy (OPAT) has been recognised as a useful, cost-effective a...
Since its introduction in the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has become a...
Purpose The development and implementation of a pharmacist-managed outpatient parenteral antimicrobi...
In healthcare, there has been a growing emphasis on establishing quality care at a low price. To ach...
We have witnessed major shifts in the delivery of health care from the hospital to community setting...
PURPOSE: This narrative review aims to describe barriers of outpatient parenteral antimicrobial ther...
Contains fulltext : 225336.pdf (Publisher’s version ) (Open Access)Triazole resist...
People who inject drugs (PWID) are susceptible to endovascular and deep-seated infections which requ...
Introduction: Outpatient parenteral antimicrobial therapy (OPAT) has gained popularity since its fir...
Objective: Evaluate evidence of the efficacy, safety, acceptability and cost-effectiveness of outpat...
Traditionally, outpatient parenteral antimicrobial therapy (OPAT) is used to treat infections with p...
Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients w...
Background Antifungal administration via outpatient parenteral antimicrobial therapy (OPAT) is in...
WHAT IS KNOWN AND OBJECTIVE: Outpatient parenteral therapy (OPAT) has become a safe and effective mo...
Aim Outpatient parenteral antimicrobial therapy (OPAT) is an option in patients who require parente...
Outpatient parenteral antimicrobial therapy (OPAT) has been recognised as a useful, cost-effective a...
Since its introduction in the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has become a...
Purpose The development and implementation of a pharmacist-managed outpatient parenteral antimicrobi...
In healthcare, there has been a growing emphasis on establishing quality care at a low price. To ach...
We have witnessed major shifts in the delivery of health care from the hospital to community setting...
PURPOSE: This narrative review aims to describe barriers of outpatient parenteral antimicrobial ther...
Contains fulltext : 225336.pdf (Publisher’s version ) (Open Access)Triazole resist...
People who inject drugs (PWID) are susceptible to endovascular and deep-seated infections which requ...
Introduction: Outpatient parenteral antimicrobial therapy (OPAT) has gained popularity since its fir...
Objective: Evaluate evidence of the efficacy, safety, acceptability and cost-effectiveness of outpat...
Traditionally, outpatient parenteral antimicrobial therapy (OPAT) is used to treat infections with p...